SmarterDividends
NVSEF

Novartis AG

NVSEF

Healthcare · Stock · annual payer

$153.00

Undervalued · +28% Add to Portfolio

Forward Yield

3.12%

Annual Dividend

$4.73

Payout Ratio

66%

5-Yr Growth

6.4%

Ex-Date

Mar 10, 2026

Frequency

Annual

Summary

As of July 2026, Novartis AG (NVSEF) yields 3.12% ($4.73 per share annually), with a blended fair-value estimate of $194.45 — +28% upside, so it screens as undervalued. Dividend safety grade: C (61/100). 6 years of dividend growth.

Is NVSEF a good dividend stock?

Yes, with caveats

Novartis AG (NVSEF) pays a annual dividend yielding 3.12% ($4.73/yr), with 6 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.

Advantages

  • Strong 6.4% 5-yr dividend growth
  • 71% total price return over 5 years

Risks

  • Cut its dividend in 2019

Key Data

Dividend Yield
3.12%
Payout Ratio
66%
Annual Dividend
$4.73
5-Yr Avg Growth
6.4%
Ex-Dividend Date
Mar 10, 2026
Years of Growth
6
Frequency
annual
Beta
0.49
Market Cap
$291.9B
P/E Ratio
21.9
5-Yr Total Return
71%
52-Week Range
$110.74 – $171.29
Dividend Safety
C · 61/100
Ever Cut?
Yes (2019)
NVSEF ex-dividend date & scheduleNext ex-date Mar 10, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $4.73 / yr per share

Per payment (annual)$473.00
Annual$473.00
Monthly avg$39.42